Award
Delivery Order #SPE2D326F7403
Short-Term Delivery Order for Diphenhydramine Vials to DoD by Fresenius Kabi
Buyer
Defense Logistics Agency
Award Amount
$70.11
Ceiling
$70.11
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2D326F7403
NAICS
325411
This award represents a delivery order under a long-term indefinite delivery contract held by Fresenius Kabi, LLC, a pharmaceutical company specializing in critical medical supplies for the U.S. Department of Defense. The contract specifically procures diphenhydramine 50 mg/ml vials, a medication vital for addressing allergic reactions and other medical conditions in military settings. This short-term award supports ongoing medical readiness by replenishing essential pharmaceutical stock within a concise performance window of a few days. The underlying indefinite delivery contract was competitively awarded, emphasizing the government's commitment to reliable and responsible procurement of defense healthcare products. The contract builds upon Fresenius Kabi's established role in supplying critical pharmaceuticals, ensuring continued operational medical support. The delivery order complements the overarching contract's multi-year timeline, reinforcing the availability of key medicines to the U.S. Armed Forces.
Description
4571084390!DIPHENHYDRAMINE 50 MG/ML VIALML